Search

everythinglearnresearchcommunity

for

Search:↓

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

Changes in gut bacteria might influence alopecia areata.

Severe alopecia areata may increase the risk of heart-related diseases.

Trichoscopy is a useful tool for diagnosing hair and scalp diseases without needing skin biopsies.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Patients with Alopecia Areata often have higher anxiety and depression.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

A new model uses specific blood markers to predict if children's hair loss will return.

Certain foods and supplements can help treat skin diseases alongside medication.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

The micrometer caliper is a reliable tool for measuring hair diameter for FUE surgery.

Long hair FUE, a hair transplant without shaving, is becoming more popular and surgeons should learn it.

The evaluation system improved patient selection for hair loss surgery, leading to better results and satisfaction.

Walter P. Unger suggests using advanced hair transplant techniques for broader coverage, as they provide natural results and use donor tissue efficiently, while also recommending personalized planning due to the unpredictable progression of baldness.

Thyroid issues can cause alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Telemedicine is effective for managing alopecia areata follow-ups.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

People with autism are more likely to develop alopecia areata than those without autism.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.